Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) just unveiled an announcement.
Clarity Pharmaceuticals Ltd has announced the quotation of 1,913,041 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code CU6, effective from July 1, 2025. This move is part of the company’s strategic efforts to enhance its capital structure and potentially increase its market presence, which could have significant implications for its stakeholders.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$7.00 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of radiopharmaceuticals for the treatment of serious diseases. The company is involved in the production of innovative therapies that leverage its proprietary platform technology.
Average Trading Volume: 3,020,484
Technical Sentiment Signal: Sell
Current Market Cap: A$810.1M
See more data about CU6 stock on TipRanks’ Stock Analysis page.